Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 5 January 1979:
Vol. 203. no. 4375, pp. 63 - 65
DOI: 10.1126/science.758679
Prev | Table of Contents | Next

Articles

Science, Vol 203, Issue 4375, 63-65
Copyright © 1979 by American Association for the Advancement of Science

articles

Catechol-O-methyltransferase: thermolabile enzyme in erythrocytes of subjects homozygous for allele for low activity

PD Scanlon, FA Raymond, and RM Weinshilboum

Low catechol-O-methyltransferase (COMT) activity (less than 8 units per milliliter) in the human erythrocyte is inherited as an autosomal recessive trait (COMTL). The average half-life of COMT in erythrocyte lysates incubated at 48 degrees C was significantly shorter in lysates from three subjects with low enzyme activity than in lysates from three subjects with high enzyme activity (12.5 +/- 0.9 minutes compared with 21.2 +/- 1.4 minutes, P less than .01). When the ratios of COMT activities in lysates heated at 48 degrees C for 15 minutes to enzyme activities in unheated samples were used as a measure of enzyme thermostability in blood samples from 316 randomly selected subjects, the ratios were significantly less for subjects with low enzyme activity than for subjects with higher enzyme activity. The presense of thermolabile COMT in blood of individuals homozygous for COMTL raises the possibility that the locus COMT may represent the structural gene for the human enzyme.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Breast Cancer Risk Reduction and Membrane-Bound Catechol O-Methyltransferase Genetic Polymorphisms.
Y. Ji, J. Olson, J. Zhang, M. Hildebrandt, L. Wang, J. Ingle, Z. Fredericksen, T. Sellers, W. Miller, J. M. Dixon, et al. (2008)
Cancer Res. 68, 5997-6005
   Abstract »    Full Text »    PDF »
Attentional control in Parkinson's disease is dependent on COMT val158met genotype.
C. H. Williams-Gray, A. Hampshire, R. A. Barker, and A. M. Owen (2008)
Brain 131, 397-408
   Abstract »    Full Text »    PDF »
The Catechol-O-Methyltransferase Met158 Low-Activity Allele and Association with Nonvertebral Fracture Risk in Elderly Men.
L. Stolk, J. B. J. van Meurs, M. Jhamai, P. P. Arp, J. P. T. van Leeuwen, A. Hofman, F. H. de Jong, H. A. P. Pols, and A. G. Uitterlinden (2007)
J. Clin. Endocrinol. Metab. 92, 3206-3212
   Abstract »    Full Text »    PDF »
Polymorphisms of Catechol-O-Methyltransferase in Men with Renal Cell Cancer.
Y. Tanaka, H. Hirata, Z. Chen, N. Kikuno, K. Kawamoto, S. Majid, T. Tokizane, S. Urakami, H. Shiina, K. Nakajima, et al. (2007)
Cancer Epidemiol. Biomarkers Prev. 16, 92-97
   Abstract »    Full Text »    PDF »
Catechol-O-methyltransferase Gene Polymorphisms in Benign Prostatic Hyperplasia and Sporadic Prostate Cancer..
Y. Tanaka, M. Sasaki, H. Shiina, T. Tokizane, M. Deguchi, H. Hirata, Y. Hinoda, N. Okayama, Y. Suehiro, S. Urakami, et al. (2006)
Cancer Epidemiol. Biomarkers Prev. 15, 238-244
   Abstract »    Full Text »    PDF »
Association of Genetic Polymorphisms with Serum Estrogens Measured Multiple Times During a 2-Year Period in Premenopausal Women.
G. Lurie, G. Maskarinec, R. Kaaks, F. Z. Stanczyk, and L. Le Marchand (2005)
Cancer Epidemiol. Biomarkers Prev. 14, 1521-1527
   Abstract »    Full Text »    PDF »
Oxidative Inhibition of Human Soluble Catechol-O-methyltransferase.
N. J. H. Cotton, B. Stoddard, and W. W. Parson (2004)
J. Biol. Chem. 279, 23710-23718
   Abstract »    Full Text »    PDF »
The Effects of Catechol-O-Methyltransferase Inhibition on Estrogen Metabolite and Oxidative DNA Damage Levels in Estradiol-treated MCF-7 Cells.
J. A. Lavigne, J. E. Goodman, T. Fonong, S. Odwin, P. He, D. W. Roberts, and J. D. Yager (2001)
Cancer Res. 61, 7488-7494
   Abstract »    Full Text »    PDF »
Catechol-O-Methyltransferase (COMT)-mediated Metabolism of Catechol Estrogens: Comparison of Wild-Type and Variant COMT Isoforms.
S. Dawling, N. Roodi, R. L. Mernaugh, X. Wang, and F. F. Parl (2001)
Cancer Res. 61, 6716-6722
   Abstract »    Full Text »    PDF »
Polymorphic Catechol-O-methyltransferase Gene and Breast Cancer Risk.
K. Mitrunen, N. Jourenkova, V. Kataja, M. Eskelinen, V.-M. Kosma, S. Benhamou, D. Kang, H. Vainio, M. Uusitupa, and A. Hirvonen (2001)
Cancer Epidemiol. Biomarkers Prev. 10, 635-640
   Abstract »    Full Text »    PDF »
O-Methylation of Tea Polyphenols Catalyzed by Human Placental Cytosolic Catechol-O-Methyltransferase.
B. T. Zhu, U. K. Patel, M. X. Cai, and A. H. Conney (2000)
Drug Metab. Dispos. 28, 1024-1030
   Abstract »    Full Text »
Catechol-O-methyltransferase (COMT): Biochemistry, Molecular Biology, Pharmacology, and Clinical Efficacy of the New Selective COMT Inhibitors.
P. T. Mannisto and S. Kaakkola (1999)
Pharmacol. Rev. 51, 593-628
   Abstract »    Full Text »    PDF »
Genetic Polymorphisms and Risk of Breast Cancer.
S. S. Coughlin and M. Piper (1999)
Cancer Epidemiol. Biomarkers Prev. 8, 1023-1032
   Full Text »
Human Histamine N-Methyltransferase Pharmacogenetics: Common Genetic Polymorphisms that Alter Activity.
C. V. Preuss, T. C. Wood, C. L. Szumlanski, R. B. Raftogianis, D. M. Otterness, B. Girard, M. C. Scott, and R. M. Weinshilboum (1998)
Mol. Pharmacol. 53, 708-717
   Abstract »    Full Text »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)